Table 6.
Aims | Animal model | Exposure route | Evaluated Parameters | Dosing and period | Main Results | Reference |
---|---|---|---|---|---|---|
Evaluate L. brevisa KB290 impacts against influenza virus infection in mice | Mice | Oral | Lyophilized KB290 suspended in PBS for 14 days and then intranasally infected with 50% mouse lethal dose of IFV | L. brevisa alleviated clinical symptoms, by production of IFN-α and increase of IFV-specific IgA production | Waki et al. (2014) | |
Evaluate if pretreatment of mice with L. plantarumb from the fermented Korean cabbage can increase protection against influenza virus infection | Mice | Intranasal or oral exposure | BALFs and lungs | Animals were treated once with (107 CFU/mouse) of L. plantarum DK119 strain (, 4 days prior infection with a lethal dose of influenza virus | L. plantarumb showed to be a beneficial probiotic against influenza virus infection byintranasal or oral exposure | (Park et al., 2013) |
Evaluate the therapeutic effect of CGJ on a mouse model of ovalbumin (OVA)-induced asthma by the suppression of histamine release | Mice | I.p. | BALFs, lungs | After sensitized by i.p. of OVA and then turned with OVA inhalation, animals were administered i.p. ethanol-extracted CGJ (100 mg/kg/day) for 16 days. | Efficacy of CGJEs as a dietary therapy of histamine-mediated allergic diseases, probably by inhibition of mast cell activation. | Bae, Shin, See, Chai, and Shon (2014b) |
Evaluate the health benefits of regular oral intake of nF1 against influenza virus infection | Mice | Oral | Daily oral intake (10 mg) of nF1 for 14 days followed by intranasally MLD50 of influenza A and B viruses, and the same feeding regimen for 14 days | Daily oral intake of nF1 delayed death of infected mice; increased survival rates | ( Park et al., 2018) | |
Evaluate anti-rotavirus activity by the bacterial supernatant, lysate, and the EPS from L. plantarumb | Mice | Oral | Blood, heart, and small intestine | EPS (1 mg/mouse) for 2 days prior and 5 days after pups infection with the murine rotavirus epidemic diarrhea (10 μL of 2 × 10d FFU) | Decreased the duration of diarrhea, limited epithelial lesions, reduced rotavirus replication in the small intestine, and better animal recovery by EPS | ( Kim et al., 2018) |
Evaluate the immune-stimulatory effects of L. bulgaricusc on the OSV-induced suppression of local and systemic humoral immunity in mice infected with IAV | Mice | Oral | BALFs, lungs | Daily single oral dose of 400 μL of L. bulgaricusc for 35 days. On d22, intranasal infection with 0.5 pfu IAV; followed by oral 50 μg of OSV in 100 μL of 5% methylcellulose (MC) as a vehicle or MC alone, twice daily | Regular intake of L. bulgaricusc can stimulate humoral immunity of anti-PR8-specific S-IgA and IgG in BALF and anti-PR8-specific IgG and IgA in serum against IAV infection | Takahashi, Sawabuchi, Kimoto, Sakai, & Kido, 2019 |
Evaluate if S. succinusd from doenjang normalises immune response and benefits allergic diseases | Mice | Oral | BALFs, lung, mediastinal lymph nodes, mesenchymal lymph nodes and spleen | S. succinusd (5 × 107 CFU/mouse) every other day to day 20, then sensitized and replaced by ovalbumin as an allergen | Therapeutic potential for allergic asthma, due to suppression of airway inflammation by increase in Treg (regulatory T cells) responses | ( Kim, Song, Lim, Lee, & Lee, 2019) |
Levilactobacillus brevis.
Lactiplantibacillus plantarum.
Lactobacillus bulgaricus.
Staphylococcus succinus.